|
|
Harvey Herschman
|
Distinguished Professor,
Biological Chemistry | |
Distinguished Professor,
Molecular & Medical Pharmacology
| |
Director,
Small Animal Imaging Shared Resource,
JCCC Basic Research
| |
Member,
ACCESS Program: Dept. of Biological Chemistry,
JCCC Signal Transduction and Therapeutics Program Area,
Neuroscience Graduate Program,
Cancer Molecular Imaging
|
Work Email Address:
hherschman@mednet.ucla.edu
Work Address:
Boyer Hall (MBI) Boyer Hall 341 MBI
Phone Numbers:
(310) 825-8735
|
Research Interest:
Dr. Herschman’s laboratory studies how extracellular stimuli elicit changes in cell growth and differentiation, as a result of induced transcription of "primary response" genes. One gene discovered by Dr. Herschman and his colleagues encodes a second form of cyclooxygenase (COX-2), the rate limiting enzyme in prostaglandin production and the target of a new generation of anti-inflammatory, anti-pyretic and analgesic pharmaceutical agents. The laboratory also identified synaptotagmin 4 as a depolarization-induced neuronal gene; a candidate for a mediator of depolarization-induced synaptic plasticity. Lastly, the laboratory has merged principles of cell biology, molecular biology and molecular imaging technologies to develop procedures that repetitively, non-invasively and quantitatively image reporter gene expression in intact, living animals. Current research interests center on improved therapies for colorectal cancer, and on the role of the COX-2 gene in the progression of a variety of epithelial cancers.
Dr. Herschman is Distinguished Professor in both the Department of Biological Chemistry and the Department of Molecular and Medical pharmacology. He holds the Ralph and Marjorie Crump Endowed Chair in Molecular Imaging. Dr. Herschman is the Director for Basic Research for the UCLA Jonsson Comprehensive Cancer Center, and the Principal Investigator for the UCLA in vivo Cellular and Molecular Imaging Center, a National Cancer Institute supported center for non-invasive imaging studies of cancer. He is a member of the Molecular Biology Institute, the CNSI and the Jonsson Comprehensive Cancer Center at UCLA.
|
Selected Publications:
Machado Hidevaldo B, Vician Linda J, Herschman Harvey R The MAPK pathway is required for depolarization-induced .
Journal of neuroscience research.
2008;
86(3):
593-602.
Weber Wolfgang A, Czernin Johannes, Phelps Michael E, Herschman Harvey R Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs..
Nature clinical practice. Oncology.
2008;
5(1):
44-54.
Ishikawa Tomo-o, Herschman Harvey R Two inducible, functional cyclooxygenase-2 genes are present in the rainbow trout genome..
Journal of cellular biochemistry.
2007;
102(6):
1486-92.
Sui Guodong, Lee Cheng-Chung, Kamei Ken-Ichiro, Li Hua-Jung, Wang Jin-Yi, Wang Jun, Herschman Harvey R, Tseng Hsian-Rong A microfluidic platform for sequential ligand labeling and cell binding analysis..
Biomedical microdevices.
2007;
9(3):
301-5.
Li Hua-Jung, Everts Maaike, Pereboeva Larisa, Komarova Svetlana, Idan Anat, Curiel David T, Herschman Harvey R Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter..
Cancer research.
2007;
67(11):
5354-61.
Koya Richard C, Kimura Takahiro, Ribas Antoni, Rozengurt Nora, Lawson Gregory W, Faure-Kumar Emmanuelle, Wang He-jing, Herschman Harvey, Kasahara Noriyuki, Stripecke Renata Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines..
Molecular therapy : the journal of the American Society of Gene Therapy.
2007;
15(5):
971-80.
Xu Zheng, Choudhary Shilpa, Voznesensky Olga, Mehrotra Meenal, Woodard Monica, Hansen Marc, Herschman Harvey, Pilbeam Carol Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis..
Cancer research.
2006;
66(13):
6657-64.
Kamei Ken-ichiro, Ishikawa Tomo-o, Herschman Harvey R Transgenic mouse for conditional, tissue-specific Cox-2 overexpression..
Genesis (New York, N.Y. : 2000).
2006;
44(4):
177-82.
Ishikawa Tomo-O, Herschman Harvey R Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene..
Genesis (New York, N.Y. : 2000).
2006;
44(3):
143-9.
Czernin Johannes, Weber Wolfgang A, Herschman Harvey R Molecular imaging in the development of cancer therapeutics..
Annual review of medicine.
2006;
57(3):
99-118.
Lu Gang, Kang Young Jun, Han Jiahuai, Herschman Harvey R, Stefani Enrico, Wang Yibin TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling..
The Journal of biological chemistry.
2006;
281(9):
6087-95.
Chikazu Daichi, Li Xiaodong, Kawaguchi Hiroshi, Sakuma Yoko, Voznesensky Olga S, Adams Douglas J, Xu Manshan, Hoshi Kazuto, Katavic Vedran, Herschman Harvey R, Raisz Lawrence G, Pilbeam Carol C Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002..
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
2005;
20(10):
1888-98.
Yaghoubi Shahriar S, Barrio Jorge R, Namavari Mohammad, Satyamurthy Nagichettiar, Phelps Michael E, Herschman Harvey R, Gambhir Sanjiv S Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography..
Cancer gene therapy.
2005;
12(3):
329-39.
Vician Linda J, Xu Guoping, Liu Wei, Feldman Jonathan D, Machado Hidevaldo B, Herschman Harvey R MAPKAP kinase-2 is a primary response gene induced by depolarization in PC12 cells and in brain..
Journal of neuroscience research.
2004;
78(3):
315-28.
Singh Vinita, Miranda Tina Branscombe, Jiang Wei, Frankel Adam, Roemer Martha E, Robb Victoria A, Gutmann David H, Herschman Harvey R, Clarke Steven, Newsham Irene F DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo..
Oncogene.
2004;
23(47):
7761-71.
Ferguson Gregory D, Herschman Harvey R, Storm Daniel R Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice..
Neuropharmacology.
2004;
47(4):
604-11.
Machado Hidevaldo B, Liu Wei, Vician Linda J, Herschman Harvey R Synaptotagmin IV overexpression inhibits depolarization-induced exocytosis in PC12 cells..
Journal of neuroscience research.
2004;
76(3):
334-41.
Ferguson Gregory D, Wang Hongbing, Herschman Harvey R, Storm Daniel R Altered hippocampal short-term plasticity and associative memory in synaptotagmin IV (-/-) mice..
Hippocampus.
2004;
14(8):
964-74.
Chen Ian Y, Wu Joseph C, Min Jung-Jun, Sundaresan Gobalakrishnan, Lewis Xiaoman, Liang Qianwa, Herschman Harvey R, Gambhir Sanjiv S Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery..
Circulation.
2004;
109(11):
1415-20.
Herschman Harvey R Noninvasive imaging of reporter gene expression in living subjects..
Advances in cancer research.
2004;
92(2):
29-80.
Symensma Tonia L, Martinez-Guzman DeeAnn, Jia Qingmei, Bortz Eric, Wu Ting-Ting, Rudra-Ganguly Nandini, Cole Steve, Herschman Harvey, Sun Ren COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression..
Journal of virology.
2003;
77(23):
12753-63.
Herschman Harvey R Molecular imaging: looking at problems, seeing solutions..
Science (New York, N.Y.).
2003;
302(5645):
605-8.
Liu Wei, Feldman Jonathan D, Machado Hidevaldo B, Vician Linda J, Herschman Harvey R Expression of depolarization-induced immediate early gene proteins in PC12 cells..
Journal of neuroscience research.
2003;
72(6):
670-8.
|
|